Birth Defects Research Part B Developmental and Reproductive Toxicology · 2003 · 14 citations · 62 references
PharmacyPharmacologyToxicologyDevelopmental ToxicologyMolecular ToxicologyReproductive ToxicologyArsenic ToxicologyDevelopmental NeurotoxicityDevelopmental ToxicityPerinatal ToxicologyPrenatal ToxicityPrenatal ToxicologyAdenosine Triphosphate MetabolismChronic Arsenic ExposureChronic Arsenic ToxicityGestation PeriodHuman Health EffectsInorganic Arsenic ToxicityMaternal ToxicitySkeletal Developmental Defects
BACKGROUND: Inorganic arsenic, given by injection to pregnant laboratory animals, can induce malformations. Arsenic methylation can be inhibited by periodate-oxidized adenosine (PAD). Severe human health effects from high chronic arsenic exposure have mainly been reported in populations with significant levels of malnutrition, which may enhance toxicity by diminishing arsenic methylating capacity. This study sought to determine the effect of inhibition of arsenic methylation on the developmental toxicity of arsenic in a mammalian model. METHODS: PAD (100 microM/kg, i.p.), was given to pregnant CD-1 strain mice 30 min before 7.5mg/kg sodium arsenite [As(III)], i.p., or 17.9 mg/kg sodium arsenate [As(V)], i.p., on gestation day 8 (GD 8; copulation plug = GD 0). Control dams received As(III), As(V), or PAD alone or were untreated. Test dams were killed on GD 17, and their litters were examined for mortality and gross and skeletal defects. RESULTS: Pretreatment with PAD before either arsenical resulted in increased maternal toxicity and lower fetal weights. Pretreatment also caused higher prenatal mortality, with 8 of 21 and 5 of 17 litters totally resorbed in the PAD plus As(III) and PAD plus As(V) treatment groups, respectively. Significant increases in the incidences of exencephaly, ablepharia, and anomalies of the vertebral centra, sternebrae, and ribs were also associated with PAD pretreatment. Short tail (3 fetuses in 3 litters) was seen only following PAD plus As(III) treatment. CONCLUSIONS: These results demonstrate that the developmental toxicity of inorganic arsenic can be enhanced by PAD, due possibly to inhibited methylation of arsenic.
62
Biostatistics: A Foundation for Analysis in the Health Sciences.
W. W. Daniel · Biometrics · 1995 · 1.1K citations
International Journal of Biochemistry · 1994 · 941 citations
J. P. Buchet, Robert Lauwerys, Harry A. Roels · International Archives of Occupational and Environmental Health · 1981 · 535 citations
Principles of Biochemistry (2nd edn)
DA Harris · Trends in Biochemical Sciences · 1993 · 405 citations